Founded in 1986, ILSI Europe fosters collaboration among the best scientists from industry, academia and the public sector to provide evidence-based scientific solutions and to pave the way forward in nutrition, food safety, consumer trust and sustainability. To deliver science of the highest quality and integrity, scientists collaborate and share their unique expertise in expert groups, workshops, symposia and resulting publications. Whereas ILSI Europe’s activities are mainly funded by its member companies, academic experts involved in our activities contribute through their voluntary work. In addition, ILSI Europe receives funding from the European Union-funded projects they partner with and projects initiated by Member States’ national authorities.
Our scientific portfolio is organised around 6 overarching themes: food safety; exposure and intake assessment; biomarkers and functional effect measurements; gut microbiota and health; nutrition, development and healthy ageing; consumer trust and sustainability. This mapping ensures a multidisciplinary approach and cross-fertilisation in our activities.
We build multi-stakeholder science-based solutions for a sustainable and healthier world.
- We foster collaboration between relevant stakeholders;
- We identify existing and emerging challenges in food, nutrition and health and facilitate proactive practical solutions;
- We communicate and disseminate our scientific output widely;
- Our way of working is designed to deliver science of the highest quality and integrity.
*Chair, Vice-Chair, President, Vice-President, Treasurer
Founded in 1978, the International Life Sciences Institute (ILSI) is a non-profit, worldwide foundation that seeks to improve the well-being of the general public through the advancement of science. Its goal is to further the understanding of scientific issues relating to nutrition, food safety, toxicology, risk assessment, and the environment. ILSI is recognised around the world for the quality of the research it supports, the global conferences and workshops it sponsors, the educational projects it initiates, and the publications it produces. ILSI’s headquarters are in Washington, DC.
ILSI branches include Argentina, Brazil, Europe, Focal Point in China, India, Japan, Korea, Mesoamerica, Mexico, North America, North Andean, South Africa, South Andean, Southeast Asia Region and Taiwan. The ILSI family also includes two entities: the Research Foundation (RF) and the Health and Environmental Sciences Institute (HESI). Each branch is independent and is funded primarily by its industry members.
The ILSI family also includes the Research Foundation (RF).
The General Assembly of Members provides the programme and financial oversight for all ILSI Europe activities and is the ultimate decision-making body upon which all member companies are represented. The General Assembly elects the members of the Board of Directors.
58 Member Companies (as of March 2017)
|Abbott Nutrition||Institut Mérieux||Red Bull|
|ADM||Johnson & Johnson EAME||Roquette Group|
|Ajinomoto Europe||Kao Corporation||Schwabegroup|
|Barilla G&R Fratelli||Lucozade Ribena Suntory||SQM Europe|
|BASF SE||Luigi Lavazza||Südzucker Group|
|Caelus Health||Mars Chocolate||Swiss Quality Testing Services - SQTS|
|Cargill||Mayr-Melnhof Karton||Tate & Lyle|
|Chr. Hansen||Mead Johnson Nutrition||Tereos|
|Cosucra Groupe Warcoing||Merck||Tetra Pak|
|Danone||Mondelēz Europe||The Coca-Cola Company|
|Dow Europe||Monsanto Europe||The Valspar Company|
|DSM||Nestlé||Tine SA R&D|
|DuPont Nutrition & Health||Nexira||Ülker Bisküvi|
|Fresenius Kabi||Pfizer Consumer Healthcare||WALA Heilmittel|
|FrieslandCampina||Pierre Fabre Dermo-Cosmétique||Yakult Europe|
|General Mills||PPG Industries||Yili Innovation Center Europe|
|Givaudan International||Premier Foods|
|Indoor Biotechnologies||Procter & Gamble|
Every year, one third of the members of the Board of Directors is on rotation. Chaired by the President of ILSI Europe, the Nomination Committee recommends candidates to the General Assembly to fill the vacancies in the Board of Directors based on their expertise, their prestige and their availability for active contribution. The Committee is composed of the President, the Chair of the Board of Directors, two industry non-director members, and two non-industry, non-director scientists of international renown nominated by the General Assembly and representing different geographical regions of Europe. The Board of Directors recommends candidates to the General Assembly to fill vacancies in the Nomination Committee.
Members of the Nomination Committee
|Non-industry Members||Industry Members|
|Prof. Alan Boobis – Chair ad interim*||Prof. John O’Brien*|
|Imperial College London (UK)||Nestlé (CH)|
|Prof. em Gérard Pascal (retired)||Dr Anne Franck|
|INRA (FR)||Cargill (BE)|
|Prof. em. Brian McKenna|
|University College Dublin (IE)|
|Prof. Diána Bánáti – ex officio|
|ILSI Europe (BE)|
The Board of Directors is composed of an equal number of member company representatives and scientists from academic institutions in order to ensure a balanced input. Each year, one third of the members retires but is eligible for re-election. Candidates recommended by the Nomination Committee to fill the Board vacancies are elected for a three-year term by the General Assembly. (The Members of the Board of Directors proposed to create a ‘Past President’ position)
The remit of the Board of Directors is to direct and control the management of ILSI Europe, such as:
- To elect the Board Officers from the members of the Board of Directors;
- To prepare the annual accounts and to propose the budget of the forthcoming year;
- To propose amendments to the Charter of Incorporation, changes in the structure of the Institute or the dissolution of the Institute to the General Assembly.
It also directs and controls the scientific activities of ILSI Europe, such as:
- Approving the scientific content of the programme, following the advice of the Scientific Advisory Committee, ensuring its execution, and reporting back on the progress and status of the programme to the General Assembly;
- Appointing the members of the Scientific Advisory Committee and proposing the establishment or dissolution of scientific committees to the General Assembly.
Members of the Board of Directors (as of January 2017)
|Non-Industry Members||Industry Members|
|Prof. Alan Boobis – President ad Interim*||Prof. John O’Brien – Chairman*|
|Imperial College London (UK)||Nestlé (CH)|
|Prof. Wim Saris – Vice-President||Dr Stephen French – Vice-Chairman*|
|University of Maastricht (NL)||Mars Chocolate (UK)|
|Prof. Gerhard Eisenbrand – Past President**||Prof. Peter Weber – Treasurer*|
|University of Kaiserlautern (DE)||DSM (CH)|
|Prof. Albert Flynn||Prof. Robert Hamer|
|University College Cork (IE)||Unilever (NL)|
|Prof. Mike Gibney||Dr Simon Metz Pedersen|
|University College Dublin (IE)||Arla Foods (DK)|
|Prof. Klaus Grunert||Dr Mariusz Michalik|
|University of Aarhus (DK)||PepsiCo International (US)|
|Prof. Richard Hurrell||Prof. Colette Shortt|
|Federal Institute of Technology – ETH (CH)||Johnson & Johnson EAME (UK)|
|Prof. Dietrich Knorr||Dr Julian Stowell|
|European Federation of Food Science & Technology (EFFoST) (AT)||DuPont Nutrition & Health (UK)|
|Prof. Gerhard Rechkemmer|
|Max Rubner-Institut – Federal Research Institute of Nutrition & Food (DE)|
|Prof. Árpád Somogyi|
|Hungarian Academy of Science (HU)|
**The Board of Directors proposed to create a Past-President position
The Scientific Advisory Committee (SAC) is composed of a maximum of 20 experts with more than 50% coming from the non-industry sector. It is chaired by the President of ILSI Europe and vice-chaired by the Vice-President. The members of the SAC are appointed for a three-year term by the Board of Directors according to their relevant expertise, their prestige and availability for active contribution. SAC members can serve a maximum of two terms.
The tasks of the Scientific Advisory Committee are:
- To review and endorse the overall scientific programme of ILSI Europe, including the new activities with respect to their scientific validity, coherence within ILSI Europe’s programme, feasibility and urgency of the issues;
- To monitor the composition of expert groups and task forces, including the appointment of Co-Chairs and scientific advisors, to ensure scientific integrity;
- To provide scientific guidance to the task forces and expert groups;
- To identify emerging issues to be dealt with by ILSI Europe;
- To advise the Board of Directors on scientific matters.
Members of the Scientific Advisory Committee (as of February 2017)
|Non-Industry Members||Industry Members|
|Prof. Alan Boobis – Chair||Dr Anne Franck|
|Imperial College London (UK)||Cargill (BE)|
|Prof. Wim Saris – Vice-Chair||Dr Heli Hollnagel|
|University of Maastricht (NL)||Dow Europe (CH)|
|Prof. Lilia Arhné||Dr Laurent Le Bellego|
|University of Copenhagen (DK)||Danone (FR)|
|Prof. Philip Calder||Mrs Begüm Mutus|
|University of Southampton (UK)||Ülker Bisküvi (TR)|
|Prof. Louise Dye||Dr Benjamin Smith|
|University of Leeds (UK)||Firmenich (US)|
|Prof. Irfan Erol||Dr Maha Tahiri|
|University of Ankara (TR)||General Mills (US)|
|Prof. Vincenzo Fogliano||Dr Stephan Theis|
|University of Wageningen (NL)||Südzucker / BENEO Group (DE)|
|Prof. Ivonne Rietjens|
|University of Wageningen (NL)|
|Prof. Helen Roche|
|University College Dublin (IE)|
Task forces initiate, develop and manage all projects. They reach their goals and address their issues through expert groups, partnerships in European Union-funded projects, workshops, and conferences.
Task forces comprise interested company representatives and non-industry experts acting as scientific advisors. Each task force appoints a Chair, a Vice-Chair and an academic Co-Chair who will perform their duties in close collaboration with the ILSI Europe office.
The main roles of the Chair are:
- To take the lead in defining the scientific programme of the task force and ensuring its application;
- To ensure good budget management;
- To closely follow the progress of all expert groups;
- To ensure the active participation of the task force members in the various activities, such as the long-term planning of the scientific programme and the identification of emerging issues.
The main roles of the Vice-Chair are:
- To assist the task force Chair in the preparation and follow-up of meetings;
- To replace the task force Chair in meetings/conference calls when needed.
In principle, ILSI Europe foresees a rotation from the Vice-Chair to the Chair position after three years, with the possibility to extend the mandate of the Chair and Vice-Chair once (maximum two terms) if required.
Task force Co-Chairs must come from academia. Their main roles are:
- To act as scientific advisors of the task force;
- To ensure that the scientific work programme of the given task force and its expert groups is aligned with ILSI Europe’s vision and mission;
- To ensure the scientific integrity of the task force members and expert groups;
- To actively contribute to the development and follow-up of new activity proposals.
In principle, ILSI Europe foresees that the Co-Chair rotates when the task force work programme changes focus.
A new task force is created when a new activity proposal is approved by the Board of Directors, after review by the Scientific Advisory Committee and external academic reviewers, provided it does not fall within the remit of an existing task force and provided it receives the support of at least 5 member companies.
A task force is funded by its supporting member companies and is disbanded when its programme is completed or in case company support is below the required minimum of 5 supporting member companies..
Once a task force has identified a new topic of interest, it develops a new activity proposal that is first submitted to the Scientific Advisory Committee, as well as to independent external academic reviewers for their scientific review (see p. 25). Then, the proposal is submitted to the Board of Directors for their review and approval. When a new activity is approved by the Scientific Advisory Committee and the Board of Directors, the task force members nominate the experts identified in the activity proposal. Expert groups comprise at least 50% scientists from academia and the public sector and up to 50% industry scientists, representing on average 10 members in total.
The expert group carries out the work outlined by the task force, e.g. collecting/analysing data/information and writing scientific papers. The output of their work is published primarily in peer-reviewed scientific journals and disseminated at relevant events. Each activity has to result in a peer-reviewed publication. A Concise Monograph or Black & White Report (ILSI Europe Report Series) may also be produced at a later stage, subject to approval by the Board of Directors.
Each expert group includes a Chair from academia and a Vice-Chair. The main roles of an expert group Chair are:
- To ensure the scientific quality of the work performed by the expert group is of a high standard, e.g. unbiased discussions and outputs resulting in a peer-reviewed publication;
- To ensure the scientific coordination of the expert group, which implies taking into account the area of expertise of each expert group member;
- To take the lead in refining new activity proposals;
- To be responsible for the publication of the scientific output (primarily in a peer-reviewed journal).
The role of an expert group Vice-Chair is to replace the expert group Chair in meetings /conference calls when needed.
ILSI Europe’s international team is responsible for the overall organisation, coordination and accomplishment of the tasks and activities entrusted to the committees, task forces and expert groups.
Staff Assignments and Project Responsibilities
|Scientific Project Manager||Task Force / Project||Project Assistant|
|Dr Pierre Dussort||Dietary Carbohydrates (DC)||Ms Toula Aslanidis|
|Process-related Compounds and Natural Toxins (PRC)||Mr Alex Rankin|
|Consumer Behaviour Determinants (CBD)||Ms Belinda Antonio|
|SUSFANS Project||Ms Belinda Antonio|
|Dr Lucie Geurts||Alternatives to Animal Testing in Food Safety, Nutrition and Efficacy Studies (AAT)||Mr Alex Rankin|
|Packaging Materials (PM)||Ms Belinda Antonio|
|Nutrition and Mental Performance (MP)||Ms Belinda Antonio|
|Netherlands Organisation for Scientific Research (NWO) Project||without need for PA|
|Dr Cyril Marsaux||Eating Behaviour and Energy Balance (EBEB)||Ms Toula Aslanidis|
|Food Allergy (FA)||Ms Toula Aslanidis|
|Threshold of Toxicological Concern (TTC) & CEFIC Project||Mr Alex Rankin|
|Pathway-27 Project||Mr Alex Rankin|
|Dr Tobias Recker||Nutrition, Immunity and Inflammation (IM) )||Ms Belinda Antonio|
|Prebiotics (PRE)||Ms Toula Aslanidis|
|Probiotics (PRO)||Ms Toula Aslanidis|
|Dr Bettina Schelkle||Early Nutrition and Long-Term Health (ENLH)||Mr Alex Rankin|
|Dietary Intake Exposure (DIET)||Mr Alex Rankin|
|Functional Foods (FF)||Mr Alex Rankin|
|New Approaches to Chemical Risk Assessment for Foods and Food Ingredients (CRA)||Mr Alex Rankin|
|Ms Lilou van Lieshout||Qualitative Fat Intake (QFI)||Mr Alex Rankin|
|Microbiological Food Safety (MFS) & EFFORT Project||Ms Toula Aslanidis|
|Nutrient Intake Optimisation (NO)||Ms Belinda Antonio|
|Obesity and Diabetes (OD)||Ms Belinda Antonio|
|Prof. Diána Bánáti||Board of Directors (BOD)||Mr Frederic Timmermans|
|Prof. Diána Bánáti / Dr Stéphane Vidry||Scientific Advisory Committee (SAC)||Mr Frederic Timmermans|
|Prof. Diána Bánáti||Nomination Committee||Ms Ruth Marquet|